As of 2025-12-16, the EV/EBITDA ratio of Profound Medical Corp (PRN.TO) is -6.62. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRN.TO's latest enterprise value is 273.36 mil CAD. PRN.TO's TTM EBITDA according to its financial statements is -41.32 mil CAD. Dividing these 2 quantities gives us the above PRN.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.4x - 18.8x | 13.1x |
| Forward P/E multiples | 14.7x - 20.5x | 17.6x |
| Fair Price | (26.72) - (34.52) | (28.02) |
| Upside | -368.0% - -446.3% | -381.0% |
| Date | EV/EBITDA |
| 2025-12-12 | -6.80 |
| 2025-12-11 | -7.00 |
| 2025-12-10 | -6.75 |
| 2025-12-09 | -6.64 |
| 2025-12-08 | -6.31 |
| 2025-12-05 | -6.14 |
| 2025-12-04 | -6.32 |
| 2025-12-03 | -6.54 |
| 2025-12-02 | -5.76 |
| 2025-12-01 | -6.05 |
| 2025-11-28 | -6.15 |
| 2025-11-27 | -6.22 |
| 2025-11-26 | -6.09 |
| 2025-11-25 | -6.16 |
| 2025-11-24 | -5.75 |
| 2025-11-21 | -5.63 |
| 2025-11-20 | -5.48 |
| 2025-11-19 | -5.70 |
| 2025-11-18 | -5.78 |
| 2025-11-17 | -6.13 |
| 2025-11-14 | -6.40 |
| 2025-11-13 | -6.12 |
| 2025-11-12 | -6.13 |
| 2025-11-11 | -6.13 |
| 2025-11-10 | -5.63 |
| 2025-11-07 | -5.63 |
| 2025-11-06 | -5.58 |
| 2025-11-05 | -5.61 |
| 2025-11-04 | -5.61 |
| 2025-11-03 | -5.62 |
| 2025-10-31 | -5.62 |
| 2025-10-30 | -5.80 |
| 2025-10-29 | -5.78 |
| 2025-10-28 | -5.83 |
| 2025-10-27 | -5.18 |
| 2025-10-24 | -5.14 |
| 2025-10-23 | -4.91 |
| 2025-10-22 | -5.09 |
| 2025-10-21 | -5.51 |
| 2025-10-20 | -5.47 |
| 2025-10-17 | -5.09 |
| 2025-10-16 | -5.17 |
| 2025-10-15 | -5.36 |
| 2025-10-14 | -5.42 |
| 2025-10-10 | -5.36 |
| 2025-10-09 | -6.13 |
| 2025-10-08 | -6.27 |
| 2025-10-07 | -5.94 |
| 2025-10-06 | -5.32 |
| 2025-10-03 | -5.28 |